The effect of fatigue reduction after the intake of plasmalogen supplement.

A Study on Subjective Evaluation of Fatigue Tolerance in Mental Stress after Long-Term Intake of Supplements Containing Plasmalogen (HSOP; Hokkaido Scallop Oil Plasmalogen) - The intake of plasmalogen supplement.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000049617

Enrollment

Registered

2022-11-26

Start date

2022-11-17

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

healthy adult men and women at 18 to 60 years old.

Interventions

The group taking the plasmalogen supplement takes 2 capsules once a day. The intake period should be 70 days, and should be taken after breakfast. The group taking the placebo supplement takes 2 capsu

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Healthy men and women between the ages of 18 and 60.

Exclusion criteria

Exclusion criteria: Those with food allergies and those taking medications.

Design outcomes

Primary

Measure	Time frame
After 14 days, 28 days, 42 days, 56 days, and 70 days from the start, the Uchida-Kraepelin test was performed as a mental stress. After that, POMS and VAS are performed as subjective evaluations to evaluate mental fatigue and stress tolerance.	—

Countries

Japan

Contacts

Public ContactTakayuki Amano

Nihon Pharmaceutical University Shomu

amano@nichiyaku.ac.jp048-721-1155

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026